Results 211 to 220 of about 54,693 (255)
Some of the next articles are maybe not open access.
Interferon-gamma release assays and TB diagnosis
Drug and Therapeutics Bulletin, 2009Worldwide in 2007, there were an estimated 9.27 million new cases of active tuberculosis (TB) and 1.8 million deaths related to the disease. However, in most people with TB, the infection is 'latent'; the underlying cause, Mycobacterium tuberculosis, remains alive but patients are asymptomatic and non-infectious.
openaire +2 more sources
Usefulness of interferon-gamma release assay in diagnosis of renal tuberculosis
Infectious Diseases, 2014Correspondence: Professor Zhigang Ji, Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1#, Shuaifuyuan, Dongcheng District, Beijing, 100730, P. R. China. Tel: 86 1069156031. Fax: 86 1069156030.
Weibin, Hou +3 more
openaire +2 more sources
Interferon-gamma release assays for tuberculosis: current and future applications
Expert Review of Respiratory Medicine, 2013Interferon-gamma release assays (IGRAs) represent the first new tool to diagnose latent tuberculosis infection for more than 100 years. They have advantages over the traditional tuberculin skin test which has a poor specificity due to false-positive responses in people who are BCG vaccinated as there is a cross-reactivity of proteins present in both ...
Muhunthan, Thillai +3 more
openaire +2 more sources
Interferon gamma release assays for diagnosing active and latent tuberculosis
Expert Opinion on Medical Diagnostics, 2009In view of the continuing global epidemic of tuberculosis (TB), adequate diagnosis is crucial for controlling this disease. Two commercial interferon gamma release assays (IGRA) have become available: the QuantiFERON-TB (QFT) and the T-SPOT.TB (TSPOT). They offer an important new tool for detecting both latent and active TB.
Steven Ft, Thijsen, Ailko Wj, Bossink
openaire +2 more sources
Tuberculin skin test versus interferon-gamma release assays
Acta Clinica Belgica, 2014Dear Editor,We would like to discuss on the publication on ‘Tuberculin skin test versus interferon-gamma release assays.’1 De Keyser et al.
S S, Tin, V, Wiwanitkit
openaire +2 more sources
Screening for Mycobacterium tuberculosis Using an Interferon-Gamma Release Assay
Journal of Public Health Management and Practice, 2012The Centers for Disease Control and Prevention recommend analyzing characteristics of populations screened for Mycobacterium tuberculosis infection using interferon-gamma release assays (IGRAs).We characterized requests for IGRA analyses submitted to the first laboratory in Washington State that began to offer IGRAs as a tuberculosis screening test. In
Terri, Simpson +3 more
openaire +2 more sources
[Research agenda of interferon-gamma release assays].
Kekkaku : [Tuberculosis], 2009Recently, new diagnostic tests for tuberculosis infection that are more specific than tuberculin skin tests have been developed and have become commercially available. These tests determine interferon-gamma production after stimulation with M. tuberculosis-specific antigens, ESAT-6 and CFP-10, and are named Interferon-Gamma Release Assays (IGRA ...
Kazue, Higuchi, Nobuyuki, Harada
openaire +1 more source
Interferon-gamma Release Assays
DMW - Deutsche Medizinische Wochenschrift, 2007A Schablon, A Niehaus
openaire +1 more source
Journal of Infection and Chemotherapy, 2009
The specificity of the tuberculin skin test (TST) in the diagnosis of tuberculosis infection is seriously compromised because of extensive use of the bacille Calmette-Guérin (BCG) vaccination. The interferon-gamma release assay (IGRA), a new diagnostic using Mycobacterium tuberculosis-specific antigens has been introduced in response to these needs. In
openaire +2 more sources
The specificity of the tuberculin skin test (TST) in the diagnosis of tuberculosis infection is seriously compromised because of extensive use of the bacille Calmette-Guérin (BCG) vaccination. The interferon-gamma release assay (IGRA), a new diagnostic using Mycobacterium tuberculosis-specific antigens has been introduced in response to these needs. In
openaire +2 more sources